首页> 外文期刊>Children >Acute Diarrhoea in Children: Determination of Duration Using a Combined Bismuth Hydroxide Gel and Oral Rehydration Solution Therapy vs. Oral Rehydration Solution
【24h】

Acute Diarrhoea in Children: Determination of Duration Using a Combined Bismuth Hydroxide Gel and Oral Rehydration Solution Therapy vs. Oral Rehydration Solution

机译:儿童急性腹泻:氢氧化铋凝胶和口服补液溶液疗法与口服补液溶液联合测定持续时间

获取原文
           

摘要

Oral rehydration salt (ORS) treatment in young children with acute diarrhoea (AD) has contributed to decrease mortality associated with dehydration although effective strategies to reduce morbidity associated with this disease are required. The aim of this study was to evaluate the diarrhoea duration when using combined colloidal bismuth hydroxide gel (CBHG) and oral rehydration salt treatment compared with ORS therapy in children with AD. We designed a double-blind, randomised prospective study with treatment and control groups. Patients aged one to 12 years, with no prior pathology and with AD of less than 48 h were included. The Chi-squared and Mann-Whitney tests were used, as well as the Cox proportional hazards model and the Kaplan-Meier estimator. Patients were randomised into an ORS and CBHG treatment group and a control group for ORS plus placebo. (Average age: 3.2 years). The result of the post-treatment evaluation with respect to the average duration of AD was 25.5 h for the treated group vs. 41.5 h for the control group ( p = 0.015). The average number of stools was 4.8 in the treated group and 8.2 in the control group ( p = 0.032). We conclude that the use of CBHG plus ORS significantly reduced the duration of AD, the number of stools and the percentage of children with persistent AD after 24 h of treatment compared to the control group. AD remitted almost twice as fast in patients treated with CBHG and ORS compared to those who received ORS plus placebo.
机译:口服补液盐(ORS)治疗急性腹泻(AD)的儿童有助于降低与脱水相关的死亡率,尽管需要有效的策略来减少与该疾病相关的发病率。这项研究的目的是评估将胶体氢氧化铋胶体(CBHG)和口服补液盐治疗与ORS治疗相比,AD儿童的腹泻持续时间。我们设计了与治疗组和对照组进行的双盲,随机前瞻性研究。年龄在1到12岁之间,无既往病理,AD少于48小时的患者。使用卡方检验和Mann-Whitney检验,以及Cox比例风险模型和Kaplan-Meier估计量。将患者随机分为ORS和CBHG治疗组和ORS加安慰剂对照组。 (平均年龄:3.2岁)。关于AD平均持续时间的治疗后评估结果,治疗组为25.5 h,而对照组为41.5 h(p = 0.015)。治疗组的平均大便数量为4.8,对照组为8.2(p = 0.032)。我们得出的结论是,与对照组相比,使用CBHG加ORS显着减少了治疗24小时后的AD持续时间,粪便数量和患有AD的儿童百分比。与接受ORS加安慰剂的患者相比,接受CBHG和ORS治疗的患者的AD释放速度几乎快一倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号